ORGANIC
LETTERS
2000
Vol. 2, No. 15
2265-2267
Solid-Phase Synthesis of New
S-Glycoamino Acid Building Blocks
Laurence Jobron and Gerd Hummel*
Jerini Bio Tools GmbH, Rudower Chaussee 29, 12489 Berlin, Germany
Received May 5, 2000
ABSTRACT
Efficient synthesis of unprotected S-glycoamino acid building blocks in the solid phase by coupling a sugar 1-thiolate with iodine activated
fluoren-9-ylmethoxycarbonyl (Fmoc) protected amino acids.
Glycoconjugates have been implicated in many biological
events important in inflammation, immune response, and
tumor metastasis.1 Of special interest are glycoproteins
containing modified glycosyl amino acids, thus exhibiting
new properties. While S-glycopeptides have been isolated
from nature,2 the driving force behind the synthesis of
S-glycosides has been the production of glycopeptido-
mimetics with enhanced stability toward chemical and
enzymatic degradation.3 Several attempts have been made
to introduce the S-linkage by chemical synthesis.4 A variety
of glycosylation methods have been applied including
Koenigs-Knorr,5 glycosyl fluorides,6 Lewis acid-catalyzed
glycosylation,7 trichloroacetimidates8 and isothiouronium
salts.9 These methods generally use protected carbohydrates
and cysteine derivatives. We present here the solid-phase
synthesis of new S-glycoamino acid building blocks. The
key feature of this method is that a nucleophilic sugar
1-thiolate without protective groups is used for coupling with
an iodine activated fluoren-9-ylmethoxycarbonyl (Fmoc)/t-
Bu protected amino acid.
Hummel and Hindsgaul10 described the use of a sugar-1-
thiolate without protective groups in the solid phase as the
nucleophile for coupling with trifluoromethanesulfonate
(triflate)-activated glycosides. Since the use of triflates with
Fmoc-protected amino acids is not compatible, we decided
to prepare amino acid iodo derivatives for the synthesis of
S-glycoamino acid building blocks.
First the free acid functions of the N-Fmoc/t-Bu ester
protected glutamic and aspartic acid derivatives were reduced
to the corresponding alcohols 2, 4, 6, and 8 (Scheme 1,
(1) Varki, A. Glycobiology 1993, 3, 97. Lee, Y. C.; Lee, R. T. Acc. Chem.
Res. 1995, 28, 322. Chambers, W. H.; Brisette-Storkus, C. S. Chem. Biol.
1995, 2, 429.
(2) Lote, C. J.; Weiss, J. B. Biochem. J. 1971, 123, 25p. Lote, C. J.;
Weiss, J. B. FEBS Lett. 1971, 16, 81. Weiss, J. B.; Lote, C. J.; Bobinski,
H. Nature New Biol. 1971, 234, 25.
Scheme 1a
(3) Michael, K.; Wittmann, V.; Ko¨nig, W.; Sandow, J.; Kessler, H. Int.
J. Pept. Protein Res. 1996, 48, 59.
(4) Taylor, C. M. Tetrahedron 1998, 54, 11317.
(5) Baran, E.; Drabarek S. Pol. J. Chem. 1978, 52, 941. Gerz, M.; Matter,
H.; Kessler, H. Angew. Chem., Int. Ed. Engl. 1993, 32, 269.
(6) Nicolaou, K. C.; Chucholowski, A.; Dolle, R. E.; Randall, J. L. J.
Chem. Soc., Chem. Commun. 1984, 1155.
(7) Salvador, L. A.; Elofsson, M.; Kilberg J. Tetrahedron 1995, 51, 5643.
(8) Ka¨sbeck, L.; Kessler, H. Liebigs Ann./Recueil 1997, 165.
(9) Monsigny M. L. P.; Delay, D.; Vaculik, M. Carbohydr. Res. 1977,
59, 589.
(10) Hummel, G.; Hindsgaul, O. Angew. Chem., Int. Ed. 1999, 38, 1782.
10.1021/ol006019o CCC: $19.00 © 2000 American Chemical Society
Published on Web 06/28/2000